AdaptHealth Corp. reported $3.23B of revenue over the trailing twelve months, +4.2% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.23B (to Q2 2026). Net income: −$228M, trailing twelve months to Q2 2026. Free cash flow: $98M, trailing twelve months to Q2 2026. Operating margin: −4.8%, trailing twelve months to Q2 2026.

AHCOAdaptHealth Corp.

Healthcare

$6.08-32% 1Y

$6.08

$5.2252 weeks$13.38

AHCO as reported

AdaptHealth Corp. reported $3.23B of revenue over the trailing twelve months, +4.2% on the year before. 11 reported series are charted on this page, each one as filed.

$3.23B

Revenue, trailing twelve months · to Q2 2026 · +4.2% against the twelve months before

Net income: −$228M
Net income · −383% year on year · trailing twelve months to Q2 2026
Free cash flow: $98M
Free cash flow · −58% year on year · trailing twelve months to Q2 2026
Operating margin: −4.8%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AHCO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.23B	+4.2%	Q2 2026
Net income	−$228M	−383%	Q2 2026
EPS	−$1.68	−411%	Q2 2026
Gross margin	17%	n/a	Q2 2026
Operating margin	−4.8%	n/a	Q2 2026
Net margin	−7.3%	n/a	Q2 2026
ROE	−5.4%	n/a	Q2 2026
ROA	−1.7%	n/a	Q2 2026
ROIC	3.8%	n/a	Q1 2026
Free cash flow	$98M	−58%	Q2 2026
P/E	17.2	n/a	Q3 2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.